June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Suppression of microglial inflammatory response by sigma receptor 1 ligand (+)-Pentazocine
Author Affiliations & Notes
  • Jing Zhao
    Ophthalmology, Georgia Health Sciences University, Augusta, GA
    Vision Discovery Institute, Georgia Health Sciences University, Augusta, GA
  • Sylvia Smith
    Cell Biology and Anatomy, Georgia Health Sciences University, Augusta, GA
    Vision Discovery Institute, Georgia Health Sciences University, Augusta, GA
  • Kathryn Bollinger
    Ophthalmology, Georgia Health Sciences University, Augusta, GA
    Vision Discovery Institute, Georgia Health Sciences University, Augusta, GA
  • Footnotes
    Commercial Relationships Jing Zhao, None; Sylvia Smith, None; Kathryn Bollinger, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1595. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jing Zhao, Sylvia Smith, Kathryn Bollinger; Suppression of microglial inflammatory response by sigma receptor 1 ligand (+)-Pentazocine. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1595.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Sigma Receptor 1 (σR1) is a member of a family of membrane-associated proteins that are expressed throughout the mammalian nervous system and visceral organs. The endogenous function of σR1is not known. However, ligands for this receptor have shown robust neuroprotective effects in brain and retina. In addition, σR1 activation suppresses aspects of brain-derived microglial inflammatory response. The goal of this work is to determine whether (+)-PTZ can suppress inflammatory responses of retina-derived microglia.

Methods: Primary cultures of microglia were prepared from postnatal (1-5 days) of Sprague-Dawley rat pups. Purity of cultured microglia was confirmed by specific expression of microglia marker Iba-1 using immunocytochemistry. Purified microglia were subjected to LPS (1μg/ml) in the presence/absence of (+)-PTZ (3μM) for 1, 3, 6 or 24 hours. Supernatants were collected and TNF-α, IL-10 and MCP-1 release level were detected using ELISA assay. Nitric oxide level in the supernatant was determined using Griess assay. Intracellular ROS was detected by incubation cells with 5μM CellROX green dye followed by observation under fluorescence microscope. Immunocytochemistry was performed for detection of any morphology change. Westerns were performed to detect MAPK and NF-κB expression after the cells were treated with LPS in the presence/absence of (+)-PTZ.

Results: Our data showed that σR1 ligand (+)-PTZ suppressed microglia morphology change in response to LPS stimulation at the 6 hours time point. LPS stimulated primary retinal microglia to secret TNF-α, IL-10, MCP-1 and nitric oxide, and secretion levels were significantly decreased when the cells were pre-treated with (+)-PTZ for 30 min. LPS also stimulated intracellular ROS generation, and ROS generation was significantly inhibited by (+)-PTZ. Our western results showed that ERK, JNK and p38 MAPKs were activated when microglia were treated with LPS. (+)-PTZ inhibited MAPK phosphorylation.

Conclusions: σR1 ligand (+)-PTZ suppresses inflammatory responses of retina-derived microglia and decreases MAPK activation.

Keywords: 595 microglia • 688 retina • 615 neuroprotection  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×